My name is John Ortiz and I’m currently a P2 pharmacy student. Over the summer I was an orientation leader and currently serve as a content-focused copy editor for the Rho Chi Post, the service chair for PARE, and a career peer for Career Services. I also work at an independent pharmacy.

Currently, I’m interested in pursuing a career in medical writing or scientific communications. I find satisfaction in learning and presenting drug information and disease states. These career paths allow pharmacists to be heavily involved in developing literature and contributing to the overall therapeutic knowledge of the healthcare community. 

I like making origami and food. Mushrooms, smoothies, eggs, and garlic steak are some foods I really enjoy. I’d like to learn how to make smoked salmon and dried strawberries, which are my favorite. I also like anime and manga (One Piece, One Punch Man, and Parasyte are some of my favorites). Occasionally I read books and visit Central Park or the American Museum of Natural History during school breaks. When the night is nice enough, I stargaze. 

eMAR

Recent Posts

Oxidative Stress and Its Impact on Vitiligo

By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…

2 months ago

Thiamine Metabolic Dysfunction Syndrome: Overview, importance, MOA, and treatment

By: Archana Murugan, PharmD candidate c/o 2029 Overview             Thiamine metabolic dysfunction syndrome (TMDS) refers…

2 months ago

Updated Guidelines for the Treatment of Multidrug and Rifampin-Resistant TB and Promising New Anti-TB Drugs in Phase 2/3 Trials

By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028             The…

2 months ago

Sixth Year Perspective: Interview with Ariella Zadrima, PharmD Candidate, c/o 2026

By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…

2 months ago

Foundayo: The New Drug in the GLP-1 market

By: Sariah Grant, PharmD Candidate c/o 2027             The rise of glucagon-like peptide -1 receptor…

2 months ago

Should All Drugs be OTC? Risks and Consequences of the FDA Commissioner Statement

By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…

2 months ago